Delivering Localized Trial Access.
EmVenio Research delivers localized trial access to diverse and underserved communities.
We empower patients and embrace communities on their terms. Our research solutions cultivate a sustainable local ecosystem that benefits all stakeholders. Removing barriers and unlocking doors to innovation reduces risk and time associated with clinical research, while improving ROI.
On February 23, 2024, EmVenio Research became part of PCM Trials. The combined organization is now the largest independent DCT site network and the most experienced provider of local clinical trial access globally. Combining PCM Trials’ market leadership in mobile visits and EmVenio’s community-based mobile site network allows us to significantly reduce research participation challenges and improve participants’ overall experience in clinical trials. Click here to learn more.
45+ Community Research Sites Activated
190+ EmVenio Mobile Clinicians Deployed
It all starts local.
Local Clinical Trial Access
Local to YOU
Of EmVenio’s trial participants from minority populations, compared to a less than 20% industry average.
Retention rate for EmVenio trial participants, compared to a 70% industry average.